Studies on Hepatic Transport and Metabolism of Bilirubin, Bile Acids, and Other Organic Substances.

胆红素、胆汁酸和其他有机物质的肝脏运输和代谢研究。

基本信息

项目摘要

To elucidate hepatocyte transport and metabolism of organic ions and its relevance to clinical medicine, the following studies were perfomed. (1) Uptake of pravastatin, an organic anion excreted into bile, by hepatocyte canalicular membrane vesicles (CMV) from normal and congenitally jaundiced Eisai hyperbilirubinuria rats (EHBR) was studied. Pravastatin uptake was stimulated in the co-presence of ATP and transmembrane upward pH gradient. This transport was absent in EHBR.These results indicate that this transport system may physiologically transport organic anions through canalicular membrane.(2) Bile canalicles were ligated (BDL) and uptakes of radiolabeled taurocholate and pravastatin were observed. Both of the transports decreased markedly 2 days after BDL.This will give pathophysiological basis for reduced bile flow after release of obstrucrive jaundice in clinical medicine. (3) Gilbert's and Type II Crigler-Najjar syndromes are characterized by the decrease in te hepatic microsomal bilirubin UDP-glucuronosyltransferase (BUGT ; UGT 1^<**>1) to 30 and 10 % of the normal activity, respectively. The genes for BUGT was analyzed mainly in Gilbert's syndrome, and heterozygous mis-sense mutations were found in the coding region or homozygous TATA box mutation (presence of additional TA) was found in the promoter region in the most of the cases. These results indicate that Gilbert's syndrome is inherited both as a dominant and a recessive trait.(4) In the liver of patients with Rotor's syndrome, we found no immunohistochemical staining of glutathione S-transferase (GST), indicating the absence of whole GST isozymes in the hepatocytes. (5) The above results were discussed refering to the litratures on the metabolism and transport of bilirubin and other organic anions.
为了阐明肝细胞对有机离子的转运和代谢及其与临床医学的相关性,进行了以下研究。(1)本文研究了正常和先天性黄疸型高胆红素尿大鼠(EHBR)肝细胞小管膜囊(CMV)对胆汁中有机阴离子普伐他汀的摄取。在ATP和跨膜向上pH梯度的共同存在下,普伐他汀摄取被刺激。这些结果表明,该转运系统可能是有机阴离子通过小管膜的生理性转运系统。(2)结扎胆管(BDL),观察放射性标记的牛磺胆酸盐和普伐他汀的摄取。BDL后2天,这两种转运量均明显减少,这为临床上梗阻性黄疸解除后胆汁流量减少提供了病理生理学依据。(3)吉尔伯特综合征和II型Crigler-Najjar综合征的特征在于肝微粒体胆红素UDP-葡萄糖醛酸基转移酶(BUGT ; UGT 1^** 1)分别降低至正常活性的30%和10%。BUGT基因主要在吉尔伯特综合征中进行分析,大多数病例在编码区发现杂合错义突变或在启动子区发现纯合TATA盒突变(存在额外的TA)。这些结果表明,吉尔伯特综合征是遗传作为一个显性和隐性性状。(4)在转子综合征患者的肝脏中,我们没有发现谷胱甘肽S-转移酶(GST)的免疫组化染色,这表明在肝细胞中没有完整的GST同工酶。(5)结合胆红素等有机阴离子的代谢和转运的文献,对上述结果进行了讨论。

项目成果

期刊论文数量(62)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
足立幸彦,他: "臨床DNA診断法(分担執筆)" 金原書店, 3 (1995)
安达幸彦等:《临床DNA诊断方法(合着)》金原书店,3(1995)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sato H,Adachi Y,Koiwai O.: "The genetic basis of Gilbert's syndrome." Lancet. 347. 557-558 (1996)
Sato H、Adachi Y、Koiwai O.:“吉尔伯特综合征的遗传基础。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
宮 浩久,足立 幸彦,他: "閉塞性黄疸ラットにおける肝細胞膜の変化について." 薬理と治療. 23(Suppl.3). S573-S576 (1995)
Hirohisa Miya、Yukihiko Adachi 等人:“阻塞性黄疸大鼠肝细胞膜的变化。”药理学和治疗 23(Suppl.3)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
足立幸彦,他: "Color Atlas of Liver Disease臨床肝臓病" 日本メディカルセンター, 16 (1994)
Yukihiko Adachi 等:“肝脏疾病彩色图谱”日本医疗中心,16(1994)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sato H,Adachi Y,Uyama E,Nanno T,Keino H,Yamada Y,Koiwai O.: "Genetic inheritance of Gilbert's syndrome." Lancet. 346. 315 (1995)
Sato H,Adachi Y,Uyama E,Nanno T,Keino H,Yamada Y,Koiwai O.:“吉尔伯特综合征的遗传性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ADACHI Yukihiko其他文献

ADACHI Yukihiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ADACHI Yukihiko', 18)}}的其他基金

Hepatic and renal expression of organic anion transporters during jaundice, and improvement of transcellular organic anion transport after transfection with Multidrug Resistance-associated Protein 2(MRP2) gene.
黄疸期间肝脏和肾脏有机阴离子转运蛋白的表达,以及转染多药耐药相关蛋白2(MRP2)基因后跨细胞有机阴离子转运的改善。
  • 批准号:
    14370178
  • 财政年份:
    2002
  • 资助金额:
    $ 3.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Relationship between UGT1A1 mutation and occurrence of Gilbert's syndrome
UGT1A1突变与吉尔伯特综合征发生的关系
  • 批准号:
    10470133
  • 财政年份:
    1998
  • 资助金额:
    $ 3.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).

相似海外基金

Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
胆红素分解代谢诱导纤溶酶原激活剂抑制剂 1 (PAI-1) 恶化代谢功能障碍
  • 批准号:
    10750132
  • 财政年份:
    2024
  • 资助金额:
    $ 3.78万
  • 项目类别:
Severe neonatal hyperbilirubinemia (SNH) and the expression of UDP-glucuronosyltransferase 1A1 (UGT1A1) play key roles in the development of necrotizing enterocolitis (NEC)
严重新生儿高胆红素血症 (SNH) 和 UDP-葡萄糖醛酸基转移酶 1A1 (UGT1A1) 的表达在坏死性小肠结肠炎 (NEC) 的发生中起关键作用
  • 批准号:
    10713549
  • 财政年份:
    2023
  • 资助金额:
    $ 3.78万
  • 项目类别:
Determining the Influence of Clinicodemographic, Biologic and SDOH Factors in Racial and Ethnic Disparities in the Prognosis of Alcohol-Associated Liver Disease
确定临床人口统计学、生物和 SDOH 因素对酒精相关性肝病预后中种族和民族差异的影响
  • 批准号:
    10785492
  • 财政年份:
    2023
  • 资助金额:
    $ 3.78万
  • 项目类别:
Mechanism of neutrophilic NCF1 in alcohol-associated liver disease pathogenesis
中性粒细胞NCF1在酒精相关性肝病发病机制中的作用机制
  • 批准号:
    10723321
  • 财政年份:
    2023
  • 资助金额:
    $ 3.78万
  • 项目类别:
Heme-, Redox-, and CO-dependent Regulation of Heme Homeostasis
血红素稳态的血红素、氧化还原和CO依赖性调节
  • 批准号:
    10660290
  • 财政年份:
    2023
  • 资助金额:
    $ 3.78万
  • 项目类别:
Immune-Metabolic Regulation of Biliary Atresia
胆道闭锁的免疫代谢调节
  • 批准号:
    10645435
  • 财政年份:
    2023
  • 资助金额:
    $ 3.78万
  • 项目类别:
The study for protection from neonatal bilirubin encephalopathy using humanized UGT1A mice
使用人源化 UGT1A 小鼠预防新生儿胆红素脑病的研究
  • 批准号:
    23K07288
  • 财政年份:
    2023
  • 资助金额:
    $ 3.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mitochondrial Dysfunction underlies treatment related hepatotoxicity in Hispanics with acute lymphoblastic leukemia
线粒体功能障碍是西班牙裔急性淋巴细胞白血病治疗相关肝毒性的基础
  • 批准号:
    10675403
  • 财政年份:
    2023
  • 资助金额:
    $ 3.78万
  • 项目类别:
A point of care-device for the determination of creatinine phosphokinase (CPK), the CPK Now
用于测定肌酸酐磷酸激酶 (CPK) 的护理点设备,CPK Now
  • 批准号:
    10822139
  • 财政年份:
    2023
  • 资助金额:
    $ 3.78万
  • 项目类别:
Identification of Early Metabolomic and Immune Endotypes of Allergy and Asthma: An Integrated Multiomics Approach
过敏和哮喘早期代谢组学和免疫内型的鉴定:综合多组学方法
  • 批准号:
    10896779
  • 财政年份:
    2023
  • 资助金额:
    $ 3.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了